NASDAQ:KNSA | Free Cash Flow | Kiniksa Pharmaceuticals International, plc

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2017-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31$50.2M$161,000.00$50.04M221.49%
2025-12-31$53.89M$633,000.00$53.26M375.10%
2025-03-31$22.32M$99,000.00$22.23M260.28%
2024-12-31$18.77M$193,000.00$18.58M
2024-03-31$3.99M$84,000.00$3.9M
2023-12-31$4.33M$56,000.00$4.27M16.92%
2023-03-31-$4.27M$24,000.00-$4.29M
2022-12-31-$11.58M-$32,000.00-$11.61M-260.21%
2022-03-31-$36.85M
2021-12-31-$18.88M$251,000.00-$19.14M
2021-03-31-$40.12M$54,000.00-$40.18M
2020-12-31-$41.19M$55,000.00-$41.25M
2020-03-31-$31.8M$223,000.00-$32.02M
2019-12-31-$24.17M$2M-$26.17M
2019-03-31-$63.26M$1.56M-$64.82M
2018-12-31-$27.64M$4.02M-$31.65M
2018-03-31-$14.97M$75,000.00-$15.05M
2017-12-31-$23.38M$4,000.00-$23.38M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31$137.99M$1.57M$136.42M231.20%
2024-12-31$25.69M$277,000.00$25.41M
2023-12-31$13.3M$130,000.00$13.17M93.52%
2022-12-31$5.81M$105,000.00$5.7M3.11%
2021-12-31-$126.3M$415,000.00-$126.71M
2020-12-31-$136.53M$283,000.00-$136.82M
2019-12-31-$158.37M$3.2M-$161.57M
2018-12-31-$81.01M$5.29M-$86.3M
2017-12-31-$50.22M$69,000.00-$50.29M